Vyvanse.com - Vyvanse Uses, Dosage, Side Effects & Warnings - Drugs.com

Provided by Alexa ranking, vyvanse.com has ranked N/A in N/A and 9,153,105 on the world. vyvanse.com reaches roughly 336 users per day and delivers about 10,085 users each month. The domain vyvanse.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 13.248.133.121 and it is a .com domain.

WebDec 25, 2023 · Vyvanse is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Vyvanse is FDA-approved to treat attention deficit hyperactivity disorder (ADHD) in adults and in children who are at least 6 years old.

List of domain same IP 13.248.133.121

Keywords on this domain

vyvanse

vyvanse medication

vyvanse generic

vyvanse shortage

vyvanse dose sizes

vyvanse vs adderall

vyvanse + depression

vyvanse side effects

vyvanse dosage

vyvanse adhd

vyvanse medicine is for what

vyvanse dosing

vyvanse website

vyvanse manufacturer

vyvanse shortage 2024

vyvanse generic launch date

vyvanse 70 mg side effects

vyvanse coupon 2024

Search Results related to vyvanse.com on Search Engine

  • Vyvanse Uses, Dosage, Side Effects & Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/vyvanse.html

    WebDec 25, 2023 · Vyvanse is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Vyvanse is FDA-approved to treat attention deficit hyperactivity disorder (ADHD) in adults and in children who are at least 6 years old.

    DA: 90 PA: 97 MOZ Rank: 14

  • Vyvanse (lisdexamfetamine): Uses, Side Effects, Dosage

    goodrx.com

    https://www.goodrx.com/vyvanse/what-is

    WebJan 3, 2023 · Vyvanse (lisdexamfetamine) is one of the first-choice medications used to treat attention deficit-hyperactivity disorder (ADHD). It can also help treat binge eating disorder (BED) in adults. Vyvanse (lisdexamfetamine) is taken once per day and can start to work within a couple hours.

    DA: 3 PA: 67 MOZ Rank: 5

  • Vyvanse: Side Effects, Uses, Coupons, Dosage, and More

    healthline.com

    https://www.healthline.com/health/drugs/vyvanse

    WebMar 18, 2024 · Vyvanse (lisdexamfetamine) is a prescription drug that’s used to treat ADHD and binge eating disorder. Vyvanse comes as oral capsules and chewable tablets. Vyvanse is used to treat: attention...

    DA: 37 PA: 86 MOZ Rank: 59

  • Vyvanse Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD

    webmd.com

    https://www.webmd.com/drugs/2/drug-148324/vyvanse-oral/details

    WebVyvanse - Uses, Side Effects, and More. Generic Name (S): lisdexamfetamine. Uses. Precautions. Uses. Lisdexamfetamine is used to treat attention deficit hyperactivity disorder ( ADHD) as part of...

    DA: 97 PA: 20 MOZ Rank: 38

  • Vyvanse: Side effects, dosage, alternatives, and more - Medical …

    medicalnewstoday.com

    https://www.medicalnewstoday.com/articles/vyvanse

    WebOct 17, 2022 · How to take. Precautions. Expiration. Drug Images. What is Vyvanse? Vyvanse is a brand-name prescription medication. It’s FDA-approved to treat the following conditions:* attention deficit...

    DA: 73 PA: 5 MOZ Rank: 81

  • Vyvanse and Dosage: Strengths, Forms, When to Take, and …

    healthline.com

    https://www.healthline.com/health/drugs/vyvanse-dosage

    WebMar 24, 2022 · Vyvanse (lisdexamfetamine) is a prescription drug for treating conditions such as attention deficit hyperactivity disorder (ADHD). The drug comes as capsules and chewable tablets. Both forms are...

    DA: 1 PA: 19 MOZ Rank: 20

  • Lisdexamfetamine Dimesylate (Oral Route) - Mayo Clinic

    mayoclinic.org

    https://www.mayoclinic.org/drugs-supplements/lisdexamfetamine-dimesylate-oral-route/description/drg-20070888

    WebApr 1, 2024 · Vyvanse. Descriptions. Lisdexamfetamine dimesylate is used to treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older. This medicine is also used to treat moderate to severe binge eating disorder (BED). It belongs to the group of medicines called central nervous system (CNS) stimulants.

    DA: 92 PA: 73 MOZ Rank: 49

  • Lisdexamfetamine - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Lisdexamfetamine

    WebLisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. Lisdexamfetamine is taken by mouth.

    DA: 37 PA: 12 MOZ Rank: 98

  • Vyvanse (Lisdexamfetamine Capsules) Information - Drugs.com

    drugs.com

    https://www.drugs.com/cdi/vyvanse-lisdexamfetamine-capsules.html

    WebDec 1, 2023 · Print. Save. Vyvanse (Lisdexamfetamine Capsules) Generic name: Lisdexamfetamine Capsules [ lis-dex-am-FET-a-meen ] Brand name: Vyvanse. Drug class: CNS stimulants. Medically reviewed by Drugs.com. Last updated on Dec 1, 2023. Uses. Before taking. Warnings. Dosage. Side effects. Overdose. FAQ. Warning. This …

    DA: 76 PA: 100 MOZ Rank: 46

  • Vyvanse ADHD Medication: Dosage, Side Effects And More

    forbes.com

    https://www.forbes.com/health/mind/what-is-vyvanse/

    WebJan 23, 2024 · Getty Creative. Table of Contents. What Is Vyvanse? Approved Uses of Vyvanse. Vyvanse Dosage. Side Effects of Vyvanse. Long-Term Risks of Vyvanse. Who Should Not Take Vyvanse? How to...

    DA: 4 PA: 33 MOZ Rank: 19

Alexa Rank

Alexa

GLOBAL RANK

9,153,105
Alexa

Alexa Reach

0.0000148403
Alexa

Page length

N/A
Alexa

Alexa Rank Country N/A

N/A
Alexa

Daily Unique Visitors

336
Alexa

Monthly Unique Visitors

10,085

Vistor via Country

Country lang
Country code
Total visitor

United States

US

2,157

Indonesia

ID

1,687

Taiwan

TW

549

United Kingdom

GB

487

Brazil

BR

441

Nigeria

NG

385

Egypt

EG

324

Hong Kong

HK

306

Canada

CA

306

Australia

AU

266

Philippines

PH

191

India

IN

186

Malaysia

MY

183

Spain

ES

151

Germany

DE

147

Mexico

MX

141

France

FR

133

Italy

IT

123

Turkey

TR

113

Iraq

IQ

103

Thailand

TH

101

Netherlands

NL

97

Israel

IL

96

Cambodia

km

80

Algeria

DZ

62

Ireland

IE

55

Romania

RO

53

Jordan

JO

49

Poland

PL

47

Ghana

GH

45

Argentina

AR

43

South Africa

ZA

39

Belgium

BE

35

Czechia

CZ

32

Ukraine

UA

30

Japan

JA

30

Morocco

MA

29

South Korea

KO

28

Lebanon

LB

27

Saudi Arabia

SA

26

Austria

AT

25

Hungary

HU

24

Sweden

SE

23

Singapore

SG

22

Pakistan

PK

21

Bangladesh

BD

20

Denmark

DK

19

Greece

GR

18

Alexa Traffic Graph

Alexa daily traffic trend graph
Alexa Statistics Graph for vyvanse.com
Alexa daily pageviews (percent) graph
Alexa Statistics Graph for www.nahklick.de
Alexa daily pageviews per user graph
Alexa Statistics Graph for vyvanse.com
Alexa time on site (in minutes) graph
Alexa Statistics Graph for www.nahklick.de
Alexa bounce rate (percent) graph
Alexa Statistics Graph for vyvanse.com
Alexa search visits graph
Alexa Statistics Graph for vyvanse.com

SEOquake Zone

Title Tips
Description Tips
Keywords Tips
Viewport Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DA
4

PA
33

MOZ Rank
19

DNS Record

Host Type Class TTL Extra
vyvanse.com A IN 300 Ip: 13.248.133.121
vyvanse.com A IN 300 Ip: 76.223.3.151
vyvanse.com NS IN 21600 Target: ns-1041.awsdns-02.org
vyvanse.com NS IN 21600 Target: ns-1583.awsdns-05.co.uk
vyvanse.com NS IN 21600 Target: ns-396.awsdns-49.com
vyvanse.com NS IN 21600 Target: ns-701.awsdns-23.net
vyvanse.com SOA IN 900 Mname: ns-1583.awsdns-05.co.uk
Rname: awsdns-hostmaster.amazon.com
Serial: 1
Refresh: 7200
Retry: 900
Expire: 1209600
Minimum-ttl: 86400
vyvanse.com MX IN 900 Pri: 10
Target: postoffice.imc2.com
vyvanse.com TXT IN 600 Txt: E9HD6QT30HCNKHPCTVLHRPO18I
Entries_0: E9HD6QT30HCNKHPCTVLHRPO18I
vyvanse.com TXT IN 600 Txt: google-site-verification: vz3zjg66il6XEe2pRNq3fOusS_sOm6_Y-A05mJhIYyw
Entries_0: google-site-verification: vz3zjg66il6XEe2pRNq3fOusS_sOm6_Y-A05mJhIYyw
vyvanse.com TXT IN 600 Txt: google-site-verification=_xgTESWabDeozh6M0NAZXOXgiYDW9S2ujBwwOmEJocg
Entries_0: google-site-verification=_xgTESWabDeozh6M0NAZXOXgiYDW9S2ujBwwOmEJocg
vyvanse.com TXT IN 600 Txt: lo9469gcaa1mru4qdg033aoi7b
Entries_0: lo9469gcaa1mru4qdg033aoi7b
vyvanse.com TXT IN 600 Txt: v=spf1 -all
Entries_0: v=spf1 -all

Hosting and Whois Zone

IP 13.248.133.121
Domain infomation Domain Name: VYVANSE.COM
Registry Domain ID: 644626614_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2024-04-10T14:52:27Z
Creation Date: 2006-10-24T14:42:57Z
Registry Expiry Date: 2024-10-24T14:42:57Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 8887802723
Domain Status: ok https://icann.org/epp#ok
Name Server: NS-1041.AWSDNS-02.ORG
Name Server: NS-1583.AWSDNS-05.CO.UK
Name Server: NS-396.AWSDNS-49.COM
Name Server: NS-701.AWSDNS-23.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2024-04-26T07:52:31Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.